Affiliation:
1. Department of General Medicine, Sri Manakula Vinayagar Medical College and Hospital, Madagadipet, Pondicherry, India
Abstract
AbstractDrug-induced lupus erythematosus is an autoimmune phenomenon where the drug exposure leads to the development of systemic lupus erythematous like clinical features. Drug-induced lupus erythematosus can be divided into systemic lupus erythematous, subacute cutaneous lupus erythematous, and chronic cutaneous lupus erythematous. Here, we report a case of a 29-year-old female presented with systemic lupus erythematous due to chronic use of proton pump inhibitors, which is considered to be very rare.
Reference8 articles.
1. Drug-related lupus;E Hess;N Engl J Med,1988
2. Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus;B J Hoffman;Arch Derm Syphilol,1945
3. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors;C Dam;Acta Derm Venereol,2008
4. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT);T Yoshimasu;Eur J Dermatol,2001
5. Drug-induced lupus erythematosus;K D Pramatarov;Clin Dermatol,1998
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献